Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Net Income (2016 - 2025)

Aethlon Medical filings provide 15 years of Net Income readings, the most recent being -$1.9 million for Q1 2025.

  • On a quarterly basis, Net Income rose 20.63% to -$1.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$9.0 million, a 25.81% increase, with the full-year FY2025 number at -$9.1 million, up 25.84% from a year prior.
  • Net Income hit -$1.9 million in Q1 2025 for Aethlon Medical, down from -$1.8 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$1.8 million in Q4 2024 to a low of -$3.8 million in Q1 2022.
  • Median Net Income over the past 5 years was -$2.6 million (2024), compared with a mean of -$2.7 million.
  • Biggest five-year swings in Net Income: plummeted 82.46% in 2022 and later surged 49.37% in 2024.
  • Aethlon Medical's Net Income stood at -$2.5 million in 2021, then fell by 12.73% to -$2.8 million in 2022, then fell by 21.63% to -$3.5 million in 2023, then soared by 49.37% to -$1.8 million in 2024, then dropped by 8.85% to -$1.9 million in 2025.
  • The last three reported values for Net Income were -$1.9 million (Q1 2025), -$1.8 million (Q4 2024), and -$2.8 million (Q3 2024) per Business Quant data.